GeneDx Holdings (WGS) Misses Q1 EPS by 29c ; Offers Guidance

GeneDx Holdings (NASDAQ: WGS) reported Q1 EPS of ($0.23), $0.29 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $87.1 million versus the consensus estimate of $78 million.

GUIDANCE:

GeneDx Holdings sees FY2025 revenue of $360-375 million, versus the consensus of $358.6 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley Starts OGE Energy (OGE) at Equalweight
• Stifel Canada Starts BlackBerry (BB) at Buy